ReviewCancers2021

Challenges with Approved Targeted Therapies against Recurrent Mutations in CLL: A Place for New Actionable Targets.

Irene López-Oreja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.